This page contains brief information about neratinib maleate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Neratinib maleate is approved to treat:
- Breast cancer that is early stage and HER2 positive. It is used as extended adjuvant therapy in patients who have already been treated with trastuzumab after surgery.
Neratinib maleate is also being studied in the treatment of other types of cancer.
More About Neratinib Maleate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Neratinib Maleate - Check for trials from NCI's list of cancer clinical trials now accepting patients.